Bluebird Bio Competitors and Similar CompaniesClear all

Bluebird Bio's competitors and similar companies include Tanvex BioPharma, G1 Therapeutics, Ionis Pharmaceuticals and Bellicum Pharmaceuticals.
Bluebird Bio
Bluebird Bio
Bluebird Bio is a developer of gene therapies for severe genetic diseases.
Tanvex BioPharma
Tanvex BioPharma
Tanvex BioPharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs.
G1 Therapeutics
G1 Therapeutics
G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer.
Ionis Pharmaceuticals
Ionis Pharmaceuticals
Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies.
Founding Date
Founding Date
1992
Founding Date
2013
Founding Date
2008
Founding Date
1989
Founding Date
2004
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Somerville, US HQ
Locations
Taipei, TW HQ
New Taipei, TW
Irvine, US
San Diego, US
San Diego, US
Locations
Durham, US HQ
Locations
Carlsbad, US HQ
Locations
Houston, US HQ
Houston, US
Houston, US
South San Francisco, US
Employees
Employees
32338% decrease
Employees
18910% increase
Employees
17015% increase
Employees
79621% increase
Employees
1386% increase
Valuation ($)
Valuation ($)
192.1 m
Valuation ($)
N/A
Valuation ($)
243.1 m
Valuation ($)
5.4 b
Valuation ($)
778.3 k
Twitter followers
Twitter followers
10.6 k
Twitter followers
N/A
Twitter followers
1.3 k
Twitter followers
4.4 k
Twitter followers
588
Number of tweets (last 30 days)
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
5.1
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
0.4
Average likes per tweet (last 30 days)
4
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
75%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
40%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A

Financial

Revenue (est.)
Revenue (est.)
$3.6m (FY, 2022)
Revenue (est.)
NT$61.4m (FY, 2023)
Revenue (est.)
$82.5m (FY, 2023)
Revenue (est.)
$787.6m (FY, 2023)
Revenue (est.)
$1.5m (FY, 2022)
Cost of goods
Cost of goods
N/A
Cost of goods
NT$1.7m (FY, 2023)
Cost of goods
N/A
Cost of goods
$9.1m (FY, 2023)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
NT$61.6m (FY, 2023)
Gross profit
N/A
Gross profit
$778.5m (FY, 2023)
Gross profit
N/A
Net income
Net income
($266.6m) (FY, 2022)
Net income
(NT$2.1b) (FY, 2023)
Net income
($48m) (FY, 2023)
Net income
($366.3m) (FY, 2023)
Net income
($25m) (FY, 2022)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
40 (FY, 2020)
Patents (US)
161 (Jun, 2021)
Patents (US)
N/A
Patents and Patent Applications
Patents and Patent Applications
1.2 k (FY, 2020)
Patents and Patent Applications
N/A
Patents and Patent Applications
350 (FY, 2020)
Patents and Patent Applications
N/A
Patents and Patent Applications
N/A

Funding

Total funding raised
Total funding raised
$ 409m
Total funding raised
$ 346.9m
Total funding raised
$ 289.6m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Tanvex BioPharma
HQ
Taipei, TW
Employees
189↑ 10% increase

Tanvex BioPharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs.

View company
G1 Therapeutics
HQ
Durham, US
Employees
170↑ 15% increase

G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer.

View company
Ionis Pharmaceuticals
HQ
Carlsbad, US
Employees
796↑ 21% increase

Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.

View company
Bellicum Pharmaceuticals
HQ
Houston, US
Employees
13

Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies.

View company